Sven Anders Ullman

Sven Anders Ullman currently works at Zydus Nycomed Healthcare Pvt Ltd., as Director.
Dr. Ullman also formerly worked at Verona Pharma Ltd., as Independent Non-Executive Director from 2015 to 2025, Social Bicycles, Inc., as Director in 2021, NTG Nordic Transport Group A, as Independent Director from 2012 to 2013, Takeda Pharmaceuticals International AG, as EVP & Director-Research & Development from 2007 to 2013, Nycomed Pharma Pvt Ltd., as Director from 2012 to 2013, Pexa AB, as Director from 2016 to 2018, Swedish Orphan Biovitrum AB, as Director & Chief Medical Officer from 2021 to 2023, Baxter International, Inc., as Executive VP, Head-Research & Development from 2013 to 2014, The Upjohn Co., as Medical Manager from 1990 to 1991, Biovitrum AB, as Chief Scientific Officer & SVP-Research, Bayer HealthCare AG, as Executive Vice President, Baxter BioScience Corp., as Head-Research & Development, Astra Draco AB, as Head-Human Pharmacology, Nycomed Asset Management GmbH, as Member-Executive Management, Nycomed GmbH, as Member-Executive Management, Sahlgrenska Universitetssjukhuset, as Head-COPD Center from 2015 to 2021, and Takeda A, as Executive Vice President-Research & Development.
Dr. Ullman received his doctorate degree from the University of Gothenburg.